Conceptus, Inc. Reports Third Quarter Diluted EPS of $0.20

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq: CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today reported financial results for the three and nine months ended September 30, 2009.
MORE ON THIS TOPIC